» Articles » PMID: 10375408

Protein Synthesis Inhibitors and Ethanol Selectively Enhance Heterologous Expression of P450s and Related Proteins in Escherichia Coli

Overview
Publisher Elsevier
Specialties Biochemistry
Biophysics
Date 1999 Jun 22
PMID 10375408
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The antibiotics chloramphenicol (Cm), tetracycline, and erythromycin, which inhibit bacterial protein synthesis and are known to induce the cold shock response, unexpectedly enhance the heterologous expression of P450s and related proteins in Escherichia coli. In contrast, antibiotics that mimic heat shock in E. coli such as puromycin, streptomycin, and kanamycin decrease the expression of the same proteins. A sublethal dose of Cm (1 microgram/ml) effectively enhances the expression of both membrane-bound proteins (microsomal and mitochondrial P450s) and a soluble mitochondrial protein (adrenodoxin) over the range of two- to eightfold. The expression level of N-terminal truncated P450c17 (1600 nmol/liter culture without Cm), for instance, reached 3500 nmol/liter culture by the addition of Cm, approximately 8.4% of the total cellular protein. Cm also enabled expression at useful levels of active P450s previously difficult to express in E. coli. In contrast, the expression of P450scc, a mitochondrial protein, is decreased by Cm but enhanced by ethanol, a powerful elicitor of heat shock response in E. coli. These results show that both the cold shock response induced by some antibiotics and the heat shock response induced by ethanol may lead to enhanced expression of certain heterologous proteins in E. coli. This study also indicates that protein synthesis inhibitors associated with the cold shock response may act as protein synthesis enhancers under certain conditions.

Citing Articles

Optimized expression and purification of a human adenosine deaminase in E. coli and characterization of its Asp8Asn variant.

Jennings M, Min S, Xu G, Homayuni K, Suresh B, Haikal Y Protein Expr Purif. 2023; 213:106362.

PMID: 37683902 PMC: 10664833. DOI: 10.1016/j.pep.2023.106362.


Expression and characterisation of human glycerol kinase: the role of solubilising agents and molecular chaperones.

Rani R, Syngkli S, Nongkhlaw J, Das B Biosci Rep. 2023; 43(4).

PMID: 37021775 PMC: 10130975. DOI: 10.1042/BSR20222258.


Use of a Baculovirus-Mammalian Cell Expression-System for Expression of Drug-Metabolizing Enzymes: Optimization of Infection With a Focus on Cytochrome P450 3A4.

Miyauchi Y, Kimura A, Sawai M, Fujimoto K, Hirota Y, Tanaka Y Front Pharmacol. 2022; 13:832931.

PMID: 35295333 PMC: 8919721. DOI: 10.3389/fphar.2022.832931.


Synergistic Antibacterial Effect of Casein-AgNPs Combined with Tigecycline against .

Chen Y, Wang W, Lin S, Yang-Wang Y, Tseng S, Chien C Polymers (Basel). 2021; 13(9).

PMID: 34068784 PMC: 8126194. DOI: 10.3390/polym13091529.


Challenges Associated With the Formation of Recombinant Protein Inclusion Bodies in and Strategies to Address Them for Industrial Applications.

Bhatwa A, Wang W, Hassan Y, Abraham N, Li X, Zhou T Front Bioeng Biotechnol. 2021; 9:630551.

PMID: 33644021 PMC: 7902521. DOI: 10.3389/fbioe.2021.630551.